Company Filing History:
Years Active: 2007-2009
Title: Innovations by Elizabeth Ashley Rouse
Introduction
Elizabeth Ashley Rouse is an accomplished inventor based in Edison, NJ (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target glucagon receptors. With a total of 2 patents, her work is focused on addressing critical health issues such as type 2 diabetes mellitus.
Latest Patents
Rouse's latest patents include "Benzamidazoles, compositions containing such compounds and methods of use" and "Cyclic guanidines, compositions containing such compounds and methods of use." The first patent relates to substituted benzimidazoles that serve as glucagon receptor antagonists, which are useful for treating, preventing, or delaying the onset of type 2 diabetes mellitus. The second patent also focuses on cyclic guanidines with similar therapeutic applications.
Career Highlights
Elizabeth Rouse is currently employed at Merck & Company, Inc., where she continues to innovate and develop new pharmaceutical solutions. Her expertise in medicinal chemistry has positioned her as a valuable asset in the research and development sector.
Collaborations
Some of her notable coworkers include Emma R Parmee and Ronald M Kim, who collaborate with her on various projects within the company.
Conclusion
Elizabeth Ashley Rouse's contributions to the field of pharmaceuticals through her innovative patents highlight her commitment to improving health outcomes. Her work exemplifies the impact of dedicated inventors in addressing significant medical challenges.